ACTA1 and cancer: EGFP+ cancer cells, upon acquisition of mesenchymal features that include expression of αSMA, irreversibly lose EGFP expression (with the entire EGFP sequence permanently removed by the Cre‐loxP mechanism) and express tdTomato.